Finger length predicts prostate cancer risk: study

Dec 01, 2010

Men whose index fingers are longer than their ring, or fourth, fingers run a significantly lower risk of prostate cancer, according to a study published Wednesday in the British Journal of Cancer.

The chances of developing the disease drop by a third, and even more in younger men, the study found.

"Our results show that relative finger length could be used as a simple test for risk, particularly in men aged under 60," said Ros Eeles, a professor at the Institute of in Britain and co-author of the study.

Finger pattern could help identify which men should undergo regular screening, especially in combination with genetic testing or other risk factors such as a family history of the disease, she said.

From 1994 to 2009, Eeles and colleagues questioned more than 1,500 prostate cancer patients in Britain, along with 3,000 healthy control cases.

For more than half the men, the index was shorter than the ring finger. Compared to this group, men whose index and ring fingers were the same length -- 19 percent of the cohort -- had a similar prostate cancer risk.

But when the index finger was longer, the risk of developing the disease dropped by 33 percent.

Men under 60 were 87 percent less likely to be in the cancer group.

The relative length of the two fingers in question -- set before birth -- appears to be a marker of different levels of to which a baby is exposed in the womb, with less testosterone correlating with a longer index finger.

Earlier research has shown that testosterone promotes the growth of prostate cancer.

Underlying the unexpected connection between digits and cancer are two genes, HOXA and HOXD, that control both finger length and the development of sex organs.

Other studies have found a link between exposure to hormones before birth and the development of other diseases, including and osteoarthritis.

Explore further: Britain to map 100,000 DNA code sequences

add to favorites email to friend print save as pdf

Related Stories

Genetic marker may predict early onset of prostate cancer

May 15, 2009

Fox Chase Cancer Center researchers have identified a genetic marker that is associated with an earlier onset of prostate cancer in Caucasian men who have a family history of prostate cancer. If the data are confirmed, the ...

Recommended for you

Pepper and halt: Spicy chemical may inhibit gut tumors

9 hours ago

Researchers at the University of California, San Diego School of Medicine report that dietary capsaicin – the active ingredient in chili peppers – produces chronic activation of a receptor on cells lining ...

Expressive writing may help breast cancer survivors

11 hours ago

Writing down fears, emotions and the benefits of a cancer diagnosis may improve health outcomes for Asian-American breast cancer survivors, according to a study conducted by a researcher at the University of Houston (UH).

Taking the guesswork out of cancer therapy

17 hours ago

Researchers and doctors at the Institute of Bioengineering and Nanotechnology (IBN), Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS) have co-developed the first molecular test ...

Brain tumour cells found circulating in blood

18 hours ago

(Medical Xpress)—German scientists have discovered rogue brain tumour cells in patient blood samples, challenging the idea that this type of cancer doesn't generally spread beyond the brain.

International charge on new radiation treatment for cancer

18 hours ago

(Medical Xpress)—Imagine a targeted radiation therapy for cancer that could pinpoint and blast away tumors more effectively than traditional methods, with fewer side effects and less damage to surrounding tissues and organs.

User comments : 0